Acadia Pharmaceuticals Inc
ACAD
Common Stock
$28.73
Sector: Health Care
Industry: Biotechnology
Sub-Industry: Biotechnology
|
|
|
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
(Diluted) Earnings Per Share | -$1.34 | -$1.05 | -$1.79 | -$1.60 | -$1.94 |
Sales/Revenue | $517.24 M | $484.15 M | $441.76 M | $339.08 M | $223.81 M |
Sales Growth | 6.83% | 9.60% | 30.28% | 51.50% | 0.00% |
Gross Margin | +98.03 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | -$215.98 M | -$167.87 M | -$281.58 M | -$235.26 M | -$245.19 M |
Net Income Growth | -28.66% | 40.38% | -19.69% | 4.05% | 0.00% |
Net Margin | -41.76 | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | -$221.57 M | -$167.10 M | -$230.85 M | -$243.78 M | -$244.44 M |
Cost of Goods Sold (incl D&A) | $10.17 M | $11.95 M | $11.69 M | $11.34 M | $12.38 M |
Cost of Goods Sold (excl D&A) | $8.14 M | $8.61 M | $8.76 M | $8.58 M | $9.37 M |
Cost of Goods Growth | -14.94% | 2.25% | 3.03% | -8.35% | 0.00% |
Research & Development | $361.58 M | $239.42 M | $266.33 M | $240.39 M | $187.16 M |
Other SG&A Expenses | $0.00 M | $0.00 M | $397.52 M | $333.89 M | $271.71 M |
Interest Expense | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Income Tax | $2.53 M | $0.35 M | $0.61 M | $0.88 M | $1.26 M |
2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | |
---|---|---|---|---|
(Diluted) Earnings Per Share | -$0.26 | -$0.17 | -$0.21 | -$0.70 |
Sales/Revenue | $136.49 M | $130.71 M | $134.56 M | $115.47 M |
Sales Growth | 4.42% | -2.86% | 16.54% | -11.69% |
Gross Margin | +98.03 | 0.00 | 0.00 | 0.00 |
Net Income | -$41.73 M | -$27.18 M | -$34.01 M | -$113.06 M |
Net Income Growth | -53.50% | 20.08% | 69.92% | -162.35% |
Net Margin | -41.76 | 0.00 | 0.00 | 0.00 |
EBITDA | -$45.57 M | -$30.36 M | -$33.14 M | -$112.50 M |
Cost of Goods Sold (incl D&A) | $2.41 M | $2.14 M | $2.67 M | $2.95 M |
Cost of Goods Sold (excl D&A) | $1.92 M | $1.63 M | $2.15 M | $2.43 M |
Cost of Goods Growth | 12.97% | -19.91% | -9.59% | 15.19% |
Research & Development | $75.74 M | $81.34 M | $75.65 M | $128.86 M |
Other SG&A Expenses | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Interest Expense | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Income Tax | $0.84 M | $0.77 M | $0.44 M | $0.49 M |
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $61.59 M | $66.32 M | $56.44 M | $12.70 M | $3.31 M |
Cash and Short-Term Investment | $416.82 M | $520.71 M | $631.96 M | $697.43 M | $473.52 M |
Cash and Short-Term Investment Growth | -19.95% | -17.60% | -9.39% | 47.29% | 0.00% |
Long Term Debt | $52.70 M | $56.13 M | $44.46 M | $6.36 M | $0.00 M |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $587.81 M | $700.12 M | $782.62 M | $783.18 M | $540.20 M |
Total Assets Growth | -16.04% | -10.54% | -0.07% | 44.98% | 0.00% |
Inventories | $6.64 M | $7.88 M | $9.68 M | $6.34 M | $4.07 M |
Finished Goods | $0.00 M | $1.11 M | $1.45 M | $3.18 M | $1.11 M |
Short Term Debt | $9.31 M | $8.30 M | $5.09 M | $3.43 M | $0.00 M |
Total Liabilities | $187.40 M | $159.23 M | $155.61 M | $84.05 M | $61.12 M |
2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $61.59 M | $63.13 M | $64.43 M | $65.72 M | $66.32 M |
Cash and Short-Term Investment | $416.82 M | $436.58 M | $436.35 M | $445.98 M | $520.71 M |
Cash and Short-Term Investment Growth | -4.53% | 0.05% | -2.16% | -14.35% | 0.00% |
Long Term Debt | $52.70 M | $53.77 M | $54.69 M | $55.48 M | $56.13 M |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $587.81 M | $602.49 M | $612.77 M | $624.25 M | $700.12 M |
Total Assets Growth | -2.44% | -1.68% | -1.84% | -10.84% | 0.00% |
Inventories | $6.64 M | $5.84 M | $6.33 M | $7.01 M | $7.88 M |
Finished Goods | $0.00 M | $1.61 M | $2.08 M | $1.73 M | $1.11 M |
Short Term Debt | $9.31 M | $9.23 M | $9.02 M | $8.94 M | $8.30 M |
Total Liabilities | $187.40 M | $176.81 M | $177.92 M | $179.45 M | $159.23 M |
Expiration Date | Call To Put Ratio | Open Money on Chain |
---|---|---|
2025-01-17 | 0.21 | -$1.60 M |
Quarter | Amount | Yield |
---|
|
|